J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4S):S178-S183. doi: 10.1016/j.japh.2021.01.029. Epub 2021 Mar 3.
Published evidence is lacking to describe the pharmacist's role in medication management within an attention deficit hyperactivity disorder (ADHD) specialty clinic.
The objectives were (1) to measure the growth of an ADHD clinic in a college health center after the integration of clinical pharmacists and (2) to evaluate provider adherence to clinic policies and procedures before and after pharmacist integration.
In 2017, a pharmacist-run ADHD clinic was established at a college campus.
Pharmacists conducted collaborative initial visits with psychiatrists and independently provided follow-up appointments for patients with ADHD.
Data were extracted from the electronic health record for patients aged 18 years or older with an ADHD diagnosis who completed a medication evaluation or medication follow-up visit from July 1, 2016 to June 30, 2019. Data were excluded if it was for another visit type, was a non-ADHD clinic provider visit, or if the visit note was classified. Data before the pharmacist integration (July 1, 2016-June 30, 2017) were compared with data after the pharmacist integration (July 1, 2017-June 30, 2019). Chi-square tests of independence evaluated differences in blood pressure monitoring, heart rate monitoring, and stimulant medication contract signature between psychiatrist- and pharmacist-run appointments.
Pharmacist presence in the ADHD clinic increased from 0 full-time equivalent (FTE) to 0.2 FTE over 3 years. The number of appointments increased by 1003% (from 26 to 287). Compared with psychiatrist-run appointments, pharmacist-run appointments were more adherent to monitoring blood pressure (11% vs. 77%, P < 0.001) and heart rate (6% vs. 75%, P < 0.001), as well as clinic policy requiring a patient's signature on a stimulant medication contract (64% vs. 75%, P = 0.019).
Pharmacists can assist psychiatrists in medication management of ADHD in the college health setting. A pharmacist-psychiatrist collaboration increased quality of care and monitoring of medication adverse effects.
缺乏发表的证据来描述药剂师在注意力缺陷多动障碍（ADHD）专科诊所中的药物管理角色。
目的是（1）测量在临床药师整合后，大学健康中心 ADHD 诊所的增长，以及（2）评估提供者在药师整合前后对诊所政策和程序的遵守情况。
2017 年，在大学校园里建立了一个由药剂师管理的 ADHD 诊所。
药剂师与精神科医生进行了协作的初次就诊，并独立为 ADHD 患者提供了后续预约。
从 2016 年 7 月 1 日至 2019 年 6 月 30 日期间，从电子健康记录中提取了完成药物评估或药物随访就诊的年龄在 18 岁或以上的 ADHD 诊断患者的数据。如果是其他就诊类型、非 ADHD 诊所提供者就诊，或就诊记录被归类，则排除数据。将药师整合前的数据（2016 年 7 月 1 日至 2017 年 6 月 30 日）与药师整合后的数据（2017 年 7 月 1 日至 2019 年 6 月 30 日）进行比较。独立样本的卡方检验评估了精神科医生和药剂师管理的预约之间血压监测、心率监测和兴奋剂药物合同签署的差异。
在 ADHD 诊所，药剂师的存在从 0 个全职等效（FTE）增加到 3 年内的 0.2 FTE。预约次数增加了 1003%（从 26 次增加到 287 次）。与精神科医生管理的预约相比，药剂师管理的预约更符合监测血压（11%比 77%，P <0.001）和心率（6%比 75%，P <0.001），以及要求患者在兴奋剂药物合同上签字的诊所政策（64%比 75%，P=0.019）。
药剂师可以协助精神科医生在大学健康环境中管理 ADHD 患者的药物。药剂师-精神科医生的合作提高了药物治疗的质量和药物不良反应的监测。
